🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A conversion study of Mirapex (pramipexole) to Requip (ropinirole) controll...
Status
Completed
Location
University of Kansas Medical Center
Start Date
2006-01
Trial ID
NCT00275275
The purpose of this study is to investigate the pharmacokinetic profile of ...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-06-28
Trial ID
NCT01435915
Treatments Being Tested
This is a phase III, multicenter, randomized, double-blind, parallel group,...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-02-15
Trial ID
NCT01154166
This study is a fixed dose, dose response study to characterize the dose re...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-01-31
Trial ID
NCT01485172
Treatments Being Tested
To investigate the efficacy and the safety of ropinirole PR/XR tablets to r...
Status
Completed
Location
GSK Investigational Site
Start Date
2009-03
Trial ID
NCT00823836
Treatments Being Tested
This study in PD patients is designed to assess the affect food has on the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04
Trial ID
NCT00460148
Treatments Being Tested
This study was designed to evaluate the pharmacokinetic profile, safety and...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00434304
Treatments Being Tested
This study was designed to compare the effectiveness and tolerability of a ...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-06-20
Trial ID
NCT00331149
Treatments Being Tested
This is a double blind, fixed dose, parallel group study to characterize th...
Status
Completed
Location
GSK Investigational Site
Start Date
2012-04-02
Trial ID
NCT01494532
Treatments Being Tested
This open label extension study allows assessment of the long term safety p...
Status
Completed
Location
GSK Investigational Site
Start Date
2010-09-02
Trial ID
NCT01536574
Treatments Being Tested